Vulvodynia & Genito-Pelvic Pain (Painful Sex)
Understanding chronic vulvar pain and why pelvic floor physical therapy is often essential for treatment
What It Is
Vulvodynia is vulvar pain lasting 3 or more months without clear identifiable cause (no infection, skin disorder, or other pathology). ACOG defines it as chronic vulvar discomfort characterized by burning, stinging, irritation, or rawness.
Vulvodynia affects approximately 8-16% of women at some point. It is often underdiagnosed and undertreated, with many women seeing multiple providers before receiving proper diagnosis.
Classification
By Location
- Generalized: Pain affects entire vulva
- Localized: Pain limited to one area
- β’ Vestibulodynia (PVD): Most common - pain at vaginal opening (vestibule)
By Provocation
- Provoked: Pain with touch or pressure (intercourse, exam, tampon use)
- Spontaneous (unprovoked): Pain occurs without stimulation
- Mixed: Both provoked and unprovoked
Why It Matters
Vulvodynia significantly impacts:
- Sexual function and relationships - many women unable to tolerate intercourse
- Quality of life - chronic pain, difficulty sitting, wearing tight clothing
- Mental health - anxiety, depression, frustration from diagnostic delays
- Daily activities - exercise, tampon use, pelvic exams may be intolerable
Common Symptoms
- Burning, stinging, or rawness of vulva
- Dyspareunia (painful intercourse) - often primary presenting complaint, particularly entry pain
- Chronic vulvar discomfort (in spontaneous type)
- Pain may be constant or intermittent
- Triggered by touch, friction, pressure
- Worse with certain activities (intercourse, exercise, prolonged sitting)
Why It's Often Missed or Dismissed
Diagnostic Challenges:
- Diagnosis of exclusion: Must rule out infections, skin conditions, atrophy first
- Many providers lack expertise: Women often see multiple providers before correct diagnosis
- Dismissed as psychological: Pain is real, not "in your head," though pain affects mental health
- Pelvic floor component often missed: Many women have unrecognized hypertonic (too tight) pelvic floor
Contributing Factors
Vulvodynia cause is not fully understood. Proposed mechanisms:
- Neuropathic pain: Nerve sensitization, hyperalgesia
- Pelvic floor dysfunction: Hypertonic (too tight) pelvic floor muscles - VERY COMMON overlap
- Inflammation: Localized inflammatory response
- Hormonal: Low estrogen, especially at vestibule
- Central sensitization: Altered pain processing in CNS
- Psychosocial factors: Anxiety, depression, trauma history (not causative but may exacerbate)
How It's Diagnosed
Clinical Evaluation - Diagnosis of ExclusionβββWell-Established
- Detailed history: Pain characteristics, onset, triggers, impact on life, prior treatments
- Pelvic examination:
- β’ Cotton swab test (Q-tip test) - gently touch vestibule to map pain
- β’ Rule out visible pathology (infections, dermatologic conditions, atrophy)
- β’ Assess pelvic floor: tone, tenderness, trigger points
- Testing to rule out other causes: Wet mount, cultures if indicated, biopsy if visible lesions
Must Rule Out:
- β’ Infections (recurrent yeast, herpes, STIs)
- β’ Dermatologic: Lichen sclerosus, lichen planus, contact dermatitis
- β’ GSM (genitourinary syndrome of menopause)
- β’ Endometriosis (deep dyspareunia)
- β’ Pelvic floor dysfunction alone
- β’ Interstitial cystitis/bladder pain syndrome
Evidence-Based Treatment
ACOG recommends multidisciplinary approach. Treatment requires patience - often combination of therapies over time. This is educational information only.
Pelvic Floor Physical Therapy (PFPT)ββEmerging Evidence
Often ESSENTIAL - many women with vulvodynia have hypertonic pelvic floor. High success rates reported.
- β’ Internal manual therapy (release of trigger points)
- β’ Biofeedback
- β’ Dilator therapy
- β’ Relaxation techniques for overactive muscles
Topical MedicationsββEmerging Evidence
- Topical lidocaine (5% ointment): Apply to vestibule before intercourse or daily. Reduces pain, allows desensitization.
- Topical estrogen: If atrophy component present (especially postmenopausal)
- Topical compounded medications: Gabapentin, amitriptyline, baclofen (limited data)
Oral Medications (Neuropathic Pain Agents)ββEmerging Evidence
- Tricyclic antidepressants: Amitriptyline, nortriptyline (low doses for neuropathic pain)
- Anticonvulsants: Gabapentin, pregabalin
- SNRIs: Duloxetine, venlafaxine
Note: Take weeks-months for effect. Start low, titrate slowly.
Cognitive Behavioral Therapy (CBT) / Sex TherapyββEmerging Evidence
Addresses pain catastrophizing, fear-avoidance, improves sexual function and quality of life. Often combined with other treatments.
Lifestyle Modifications
- β’ Avoid irritants (harsh soaps, perfumed products, tight clothing)
- β’ Wear cotton underwear
- β’ Use lubricants (water-based) for intercourse
- β’ Avoid prolonged sitting (use cushion if needed)
- β’ Ice or cool packs for relief
Surgical Options (Vestibulectomy)ββEmerging Evidence
Reserved for localized provoked vestibulodynia that has not responded to conservative treatments. Success rates around 60-80% but not first-line.
What This Page Does NOT Replace
- Evaluation by specialist: Requires thorough exam to rule out other causes
- Treatment plan from provider: Treatment is multimodal and individualized
- Pelvic floor physical therapy assessment: Most women need expert PFPT evaluation
- Mental health support: CBT, sex therapy often critical components
Key Takeaways
- Vulvodynia is chronic vulvar pain lasting 3+ months without identifiable cause
- It is a diagnosis of exclusion - must rule out infections, skin conditions, atrophy
- Pelvic floor dysfunction (hypertonic muscles) very commonly overlaps
- Treatment is multidisciplinary: PFPT, medications, CBT/sex therapy
- Pelvic floor physical therapy often essential for successful treatment
- Be patient - treatment takes time, often combination approach needed
Related Resources
Pelvic Floor Dysfunction
Learn about hypertonic pelvic floor and pelvic floor physical therapy
Read More βEvidence Summary
Well-Established (βββ)
ACOG definition and diagnostic criteria, diagnosis-of-exclusion approach (cotton swab test, ruling out infections/dermatologic causes), well-documented symptom pattern
Emerging Evidence (ββ)
Multifactorial cause (neuropathic, hormonal, inflammatory, central sensitization), effectiveness of pelvic floor physical therapy, topical and oral neuropathic pain agents, CBT/sex therapy
Research Gaps (β )
Precise underlying mechanism, optimal treatment sequencing and duration, long-term outcomes of vestibulectomy, best predictors of treatment response